Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT07502118
Recruiting
NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)
Phase 2/3 · 4 sites
Registry update: 30 Mar 2026
NCT07888309
Recruiting
SCRT + Fruquintinib + Tislelizumab + CAPOX Versus SCRT + Tislelizumab + CAPOX as Neoadjuvant Therapy for Locally Advanced Low Rectal Cancer
Phase 2 · China · 1 site
Registry update: 22 Oct 2026
NCT07197138
Recruiting
IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition
Not applicable · Germany · 1 site
Registry update: 7 Oct 2026
NCT07599969
Recruiting
Bronchiectasis Phenotype Identification Model
Not applicable · Egypt · 1 site
Registry update: 20 May 2026
NCT07139132
Recruiting
The AHA Oneida Study
Not applicable · United States · 2 sites
Registry update: 4 Nov 2026
NCT07164183
Recruiting
Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis
Phase 3 · Russia · 8 sites
Registry update: 18 Sept 2025
NCT06920251
Recruiting
Phase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy
Phase 2 · South Korea · 1 site
Registry update: 3 Dec 2025
NCT07495215
Recruiting
A Clinical Study on the Safety, Tolerability and Efficacy of Neoantigen-based Personalized mRNA Therapy iNeo-Vac-R01 Plus PD-1 Inhibitor in Adjuvant Treatment of Liver Cancer Post Radical Resection
Phase 1/2 · China · 1 site
Registry update: 27 Mar 2026
NCT07049848
Recruiting
SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
Phase 2 · United States · 1 site
Registry update: 22 May 2026
NCT07174908
Recruiting
A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation
Phase 3 · China · 11 sites
Registry update: 3 Mar 2026
NCT07408024
Recruiting
Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis
Phase 2 · China · 1 site
Registry update: 1 Oct 2026
NCT07459101
Recruiting
UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-4
Not applicable · Canada · 1 site
Registry update: 23 Oct 2026
NCT07029230
Recruiting
Blood Based Assessment of sST2, Taken During and After Surgery, for Pediatric Patients With Heart Defects to Predict Heart Failure.
Not applicable · Switzerland · 1 site
Registry update: 17 Nov 2025
NCT06528769
Recruiting
Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
Phase 2 · United States · 1 site
Registry update: 1 Oct 2026
NCT07272499
Recruiting
Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease
Phase 2 · China · 1 site
Registry update: 28 Jul 2026
NCT07130903
Recruiting
Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
Phase 2 · United States · 9 sites
Registry update: 10 Nov 2025
NCT07285707
Recruiting
Acupuncture and Chinese Herbal Medicine for Long COVID
Not applicable · United States · 1 site
Registry update: 16 Dec 2025
NCT06835595
Recruiting
TMS-related Measures as Biomarker of Cognitive Impairment in PD
Not applicable · Italy · 3 sites
Registry update: 22 Dec 2025
NCT06962930
Recruiting
An Online Physical Activity Coaching Intervention for People With PD in Qatar
Not applicable · Qatar · 3 sites
Registry update: 29 Sept 2025
NCT07192965
Recruiting
ECG-less Coronary Computed Tomography Angiography in the Management of Patients Presenting With High-troponin Chest Pain
Not applicable · Belgium · 1 site
Registry update: 25 Sept 2025

Ordered by registry start date. Freshness and sponsorship never change the order.